Carregant...
In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
There are currently no effective treatments for advanced‐stage papillary renal cell carcinoma (PRCC). The goal of this study is to define potential DNA methylation‐based markers and treatment targets for advanced‐stage type 2 PRCC. Progressive DNA methylation changes and copy number variation (CNV)...
Guardat en:
| Publicat a: | Cancer Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745825/ https://ncbi.nlm.nih.gov/pubmed/31361072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2402 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|